Clinical Trial Update: Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating D-Ribose for the treatment of congestive heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• D-ribose (D-ribose)

Snippet

Sponsor: RiboCor, Inc. | Conditions: Congestive Heart Failure | Phase 2 | Status: WITHDRAWN